Kelsey P. Kubelick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kelsey P. Kubelick has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Stanislav Y. Emelianov
Wallace H. Coulter Department of Biomedical Engineering Georgia Institute of Technology and Emory University School of Medicine Atlanta Georgia USA
10 shared publications - Jinhwan Kim
Department of Biomedical Engineering University of California Davis Davis California USA
4 shared publications Myeongsoo Kim
Wallace H. Coulter Department of Biomedical Engineering Georgia Institute of Technology and Emory University School of Medicine Atlanta Georgia USA
3 shared publications- Younan Xia
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States
3 shared publications - Anamik Jhunjhunwala
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University
2 shared publications - Chenxiao Wang
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, USA
2 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Wiley in Advanced Functional Materials
Dual Nanoparticle Labeling Enables Magnet‐Assisted Delivery and Retention of Stem Cells with Longitudinal Photoacoustic Imaging
Magnetic targeting can improve localization of transplanted cells, but most implementations utilize endpoint assessments rather than real‐time longitudinal monitoring to assist and verify in vivo cell delivery and distribution. Here we develop a dual nanoparticle labeling strategy that integrates ultrasound (US) and photoacoustic (PA) imaging with magnetic guidance to enable image‐guided magnetic localization and retention of mesenchymal stromal cells (MSCs), together with quantitative longitudinal monitoring of the associated nanoparticle‐derived photocoustic signal. Silica‐coated gold nanorods provide photoacoustic contrast, while iron oxide nanoparticles introduce magnetic responsiveness, with nanoparticles altering neither MSC viability nor functionality. Combined loading yields a modular nanoparticle‐augmented cell system that responds to external magnetic fields and can be monitored before, during, and after delivery. Using both intramuscular and intravenous delivery routes, magnetic exposure increased acute localization, and the resulting nanoparticle‐associated photoacoustic signal distribution was monitored longitudinally using three‐dimensional photoacoustic metrics that quantify total signal, spatial footprint, and hotspot dynamics. Together, the platform establishes a foundation for image‐guided cellular localization and offers principles for combining orthogonal nanomaterials within a single cell to support improved retention and quantitative in vivo monitoring across cell therapy applications.
- 16 November 2026
- Published by Wiley in Advanced Functional Materials
Open AccessDual Nanoparticle Labeling Enables Magnet‐Assisted Delivery and Retention of Stem Cells with Longitudinal Photoacoustic Imaging
Magnetic targeting can improve localization of transplanted cells, but most implementations utilize endpoint assessments rather than real‐time longitudinal monitoring to assist and verify in vivo cell delivery and distribution. Here we develop a dual nanoparticle labeling strategy that integrates ultrasound (US) and photoacoustic (PA) imaging with magnetic guidance to enable image‐guided magnetic localization and retention of mesenchymal stromal cells (MSCs), together with quantitative longitudinal monitoring of the associated nanoparticle‐derived photocoustic signal. Silica‐coated gold nanorods provide photoacoustic contrast, while iron oxide nanoparticles introduce magnetic responsiveness, with nanoparticles altering neither MSC viability nor functionality. Combined loading yields a modular nanoparticle‐augmented cell system that responds to external magnetic fields and can be monitored before, during, and after delivery. Using both intramuscular and intravenous delivery routes, magnetic exposure increased acute localization, and the resulting nanoparticle‐associated photoacoustic signal distribution was monitored longitudinally using three‐dimensional photoacoustic metrics that quantify total signal, spatial footprint, and hotspot dynamics. Together, the platform establishes a foundation for image‐guided cellular localization and offers principles for combining orthogonal nanomaterials within a single cell to support improved retention and quantitative in vivo monitoring across cell therapy applications.
- Open Access
- 19 August 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (58) , e74686
Membrane‐Bound Multimodal Plasmonic Transducers for Noninvasive, In Situ Monitoring and Control of CAR T Cells Against Heterogeneous Solid Tumors
Noninvasive monitoring and control of CAR T cells against heterogeneous solid tumors remain major challenges in understanding and improving treatment response. To address this, membrane‐bound plasmonic transducers, composed of plasmonically coupled gold nanospheres in an anisotropic framework, were developed for multimodal photoacoustic imaging and localized thermal modulation of CAR T cell activity. These transducers exhibit approximately 90% absorption efficiency and photostability under laser fluences exceeding 20 mJ cm −2 , delivering photoacoustic and thermal responses over multiple lasing cycles. Membrane‐bound transducers on CAR T cells thus enable photoacoustic and thermal responsiveness upon laser excitation without compromising key cellular functions. In heterogeneous HER2‐expressing breast tumor models, longitudinal photoacoustic imaging enabled prospective stratification of tumors based on early T cell trafficking, predicting responders versus nonresponders with high sensitivity and specificity. Moreover, transducer‐mediated thermal modulation of intratumoral CAR T cells engineered with thermogenetic circuits to secrete T cell engagers redirected cytotoxicity toward antigen‐negative tumors, overcoming antigen escape and consequently enhancing therapy. Taken together, we demonstrate a strategy to noninvasively monitor and control CAR T cells against heterogeneous solid tumors via membrane‐bound multimodal transducers.
- 19 August 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (58) , e74686
Open AccessMembrane‐Bound Multimodal Plasmonic Transducers for Noninvasive, In Situ Monitoring and Control of CAR T Cells Against Heterogeneous Solid Tumors
Noninvasive monitoring and control of CAR T cells against heterogeneous solid tumors remain major challenges in understanding and improving treatment response. To address this, membrane‐bound plasmonic transducers, composed of plasmonically coupled gold nanospheres in an anisotropic framework, were developed for multimodal photoacoustic imaging and localized thermal modulation of CAR T cell activity. These transducers exhibit approximately 90% absorption efficiency and photostability under laser fluences exceeding 20 mJ cm −2 , delivering photoacoustic and thermal responses over multiple lasing cycles. Membrane‐bound transducers on CAR T cells thus enable photoacoustic and thermal responsiveness upon laser excitation without compromising key cellular functions. In heterogeneous HER2‐expressing breast tumor models, longitudinal photoacoustic imaging enabled prospective stratification of tumors based on early T cell trafficking, predicting responders versus nonresponders with high sensitivity and specificity. Moreover, transducer‐mediated thermal modulation of intratumoral CAR T cells engineered with thermogenetic circuits to secrete T cell engagers redirected cytotoxicity toward antigen‐negative tumors, overcoming antigen escape and consequently enhancing therapy. Taken together, we demonstrate a strategy to noninvasively monitor and control CAR T cells against heterogeneous solid tumors via membrane‐bound multimodal transducers.
- Open Access
- 6 August 2026
- Published by Springer Nature in Molecular Imaging and Biology
- p. 1-32
Listening to Immunotherapy – Ultrasound and Photoacoustic Imaging Strategies to Guide and Enhance Cancer Treatments
Immunotherapies are transformative strategies in modern oncology, utilizing the body’s own immune system to stimulate and enhance the antitumor immune response. Successful immunotherapies require precise delivery, real-time monitoring of immune reactions, and flexible treatment strategies that can adapt to patient-specific complexities. These conditions underscore the need for noninvasive, longitudinal imaging approaches to understand therapy progress and maximize response towards precision immunotherapies. Photoacoustic (PA) imaging, especially when integrated with ultrasound (US), is a powerful modality that is gaining momentum in the immunoimaging space. PA imaging enables label-free assessment of functional biological parameters using endogenous chromophores, while engineered exogenous contrast agents extend its capabilities for molecular and cellular imaging towards theranostic applications. These advances allow visualization of immune activity, therapeutic distribution, and treatment-induced microenvironmental changes in real-time. In this review, we focus on the integral role of US/PA imaging in guiding, optimizing, and advancing cancer immunotherapy. This review begins by outlining label-free imaging techniques and the use of exogenous contrast agents as theranostic nanoplatforms in cancer immunotherapies. Following this foundation, we explore US/PA imaging in immunotherapies, emphasizing photoimmunotherapy, adoptive cell immunotherapy, immune checkpoint blockade, and focused ultrasound mediated immunomodulation. Additionally, we highlight complementary multimodal imaging approaches that expand the scope of US/PA guided immunotherapy. Finally, we address key translational challenges, emerging innovations, and future directions for translating US/PA into routine clinical practice.
- 6 August 2026
- Published by Springer Nature in Molecular Imaging and Biology
- p. 1-32
Open AccessListening to Immunotherapy – Ultrasound and Photoacoustic Imaging Strategies to Guide and Enhance Cancer Treatments
Immunotherapies are transformative strategies in modern oncology, utilizing the body’s own immune system to stimulate and enhance the antitumor immune response. Successful immunotherapies require precise delivery, real-time monitoring of immune reactions, and flexible treatment strategies that can adapt to patient-specific complexities. These conditions underscore the need for noninvasive, longitudinal imaging approaches to understand therapy progress and maximize response towards precision immunotherapies. Photoacoustic (PA) imaging, especially when integrated with ultrasound (US), is a powerful modality that is gaining momentum in the immunoimaging space. PA imaging enables label-free assessment of functional biological parameters using endogenous chromophores, while engineered exogenous contrast agents extend its capabilities for molecular and cellular imaging towards theranostic applications. These advances allow visualization of immune activity, therapeutic distribution, and treatment-induced microenvironmental changes in real-time. In this review, we focus on the integral role of US/PA imaging in guiding, optimizing, and advancing cancer immunotherapy. This review begins by outlining label-free imaging techniques and the use of exogenous contrast agents as theranostic nanoplatforms in cancer immunotherapies. Following this foundation, we explore US/PA imaging in immunotherapies, emphasizing photoimmunotherapy, adoptive cell immunotherapy, immune checkpoint blockade, and focused ultrasound mediated immunomodulation. Additionally, we highlight complementary multimodal imaging approaches that expand the scope of US/PA guided immunotherapy. Finally, we address key translational challenges, emerging innovations, and future directions for translating US/PA into routine clinical practice.
- 8 August 2025
- Published by Springer Nature in Biomedical Engineering Letters
- Vol. 15 (6) , 1085-1096
Nanoengineered cytotoxic T cells for photoacoustic image-guided combinatorial cancer therapy
This study aims to demonstrate that surface engineering of cytotoxic T cells with drug-loaded nanoparticles enhances nanoparticle delivery to induce a more potent combinatorial chemotherapeutic and immunotherapeutic effect, as well as enabling spatial tracking through the use of non-invasive, real-time ultrasound-guided photoacoustic imaging. Ovalbumin (OVA)-targeting OT-1 T cells were functionalized with doxorubicin-loaded, mesoporous silica-coated gold nanorods. In vitro toxicity and synergistic effects were assessed using antigen-matched OVA-expressing melanoma cells, while in vivo studies evaluated therapeutic efficacy. Ultrasound-guided photoacoustic imaging was employed to confirm the targeted delivery of the nanoengineered cells. The integration of optically active, drug-loaded nanoparticles with T cells facilitates precise image-guided delivery and enhances nanoparticle accumulation within the tumor environment, thereby maximizing the combinatorial chemo-immunotherapeutic effect. The integration of optically active, drug-loaded nanoparticles with T cells facilitates precise image-guided delivery and enhances nanoparticle accumulation within the tumor environment, thereby maximizing the combinatorial chemo-immunotherapeutic effect.
- 8 August 2025
- Published by Springer Nature in Biomedical Engineering Letters
- Vol. 15 (6) , 1085-1096
Nanoengineered cytotoxic T cells for photoacoustic image-guided combinatorial cancer therapy
This study aims to demonstrate that surface engineering of cytotoxic T cells with drug-loaded nanoparticles enhances nanoparticle delivery to induce a more potent combinatorial chemotherapeutic and immunotherapeutic effect, as well as enabling spatial tracking through the use of non-invasive, real-time ultrasound-guided photoacoustic imaging. Ovalbumin (OVA)-targeting OT-1 T cells were functionalized with doxorubicin-loaded, mesoporous silica-coated gold nanorods. In vitro toxicity and synergistic effects were assessed using antigen-matched OVA-expressing melanoma cells, while in vivo studies evaluated therapeutic efficacy. Ultrasound-guided photoacoustic imaging was employed to confirm the targeted delivery of the nanoengineered cells. The integration of optically active, drug-loaded nanoparticles with T cells facilitates precise image-guided delivery and enhances nanoparticle accumulation within the tumor environment, thereby maximizing the combinatorial chemo-immunotherapeutic effect. The integration of optically active, drug-loaded nanoparticles with T cells facilitates precise image-guided delivery and enhances nanoparticle accumulation within the tumor environment, thereby maximizing the combinatorial chemo-immunotherapeutic effect.
- Open Access
- 22 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-12
Acoustic loudness factor as an experimental parameter for benchmarking small molecule photoacoustic probes
Photoacoustic imaging (PAI) is an emerging biomedical imaging modality with promise as a point-of-care diagnostic. This imaging modality relies on optical excitation of an absorber followed by production of ultrasound through the photoacoustic effect, resulting in high spatial resolution with imaging depths in the centimeter range. Herein, we disclose the discovery of the first benchmarking parameter for small molecule dye performance in PAI, which we term the acoustic loudness factor (ALF). ALF can predict dye performance in PAI without the need for access to photoacoustic instrumentation and can be used to guide the systematic evaluation of design strategies to enhance photoacoustic signal. Lastly, we demonstrate that enhancements in ALF can be translated to in vivo PAI. Akin to the use of fluorescence brightness in fluorophore design and evaluation for fluorescence imaging, we anticipate that ALF will guide the design and evaluation of improved probes for PAI.
- 22 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-12
Open AccessAcoustic loudness factor as an experimental parameter for benchmarking small molecule photoacoustic probes
Photoacoustic imaging (PAI) is an emerging biomedical imaging modality with promise as a point-of-care diagnostic. This imaging modality relies on optical excitation of an absorber followed by production of ultrasound through the photoacoustic effect, resulting in high spatial resolution with imaging depths in the centimeter range. Herein, we disclose the discovery of the first benchmarking parameter for small molecule dye performance in PAI, which we term the acoustic loudness factor (ALF). ALF can predict dye performance in PAI without the need for access to photoacoustic instrumentation and can be used to guide the systematic evaluation of design strategies to enhance photoacoustic signal. Lastly, we demonstrate that enhancements in ALF can be translated to in vivo PAI. Akin to the use of fluorescence brightness in fluorophore design and evaluation for fluorescence imaging, we anticipate that ALF will guide the design and evaluation of improved probes for PAI.
- Open Access
- 19 April 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (4) , 432
Introducing the Stool Stomper: A Device Designed to Enable Accelerated and Standardized Stool Sample Preparation Using the Kato–Katz Technique
Soil-transmitted helminths (STHs) are parasitic worms that impact over 1.5 billion people globally. The Kato–Katz technique analyzes stool samples for STHs, allowing for individual diagnoses of STH infection and the estimation of community-level prevalence. One challenge that arises with the procedure is that lab technicians often struggle to prepare microscope slides of sufficient quality for analysis after one attempt. As a result, Kato–Katz procedures are repeated, wasting time and resources. To aid technicians during in-field slide preparation, we created the Stool Stomper. The Stool Stomper is a user-friendly, handheld mechanical device that applies constant, uniform pressure to stool samples to ensure standardized sample preparation onto microscope slides to improve egg counts. The Stool Stomper was assessed using artificial eggs during in-country testing in a lab setting in Dodoma, Tanzania, by lab technicians with various experience levels, from beginner to advanced. Compared to the traditional method, we found that the Stool Stomper reduced slide preparation time, reduced artificial egg counting time, and standardized artificial egg counts with more consistent and accurate readings. The current pilot study highlights the potential for future development and integration of the Stool Stomper device into the Kato–Katz technique to improve community-based STH treatment.
- 19 April 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (4) , 432
Open AccessIntroducing the Stool Stomper: A Device Designed to Enable Accelerated and Standardized Stool Sample Preparation Using the Kato–Katz Technique
Soil-transmitted helminths (STHs) are parasitic worms that impact over 1.5 billion people globally. The Kato–Katz technique analyzes stool samples for STHs, allowing for individual diagnoses of STH infection and the estimation of community-level prevalence. One challenge that arises with the procedure is that lab technicians often struggle to prepare microscope slides of sufficient quality for analysis after one attempt. As a result, Kato–Katz procedures are repeated, wasting time and resources. To aid technicians during in-field slide preparation, we created the Stool Stomper. The Stool Stomper is a user-friendly, handheld mechanical device that applies constant, uniform pressure to stool samples to ensure standardized sample preparation onto microscope slides to improve egg counts. The Stool Stomper was assessed using artificial eggs during in-country testing in a lab setting in Dodoma, Tanzania, by lab technicians with various experience levels, from beginner to advanced. Compared to the traditional method, we found that the Stool Stomper reduced slide preparation time, reduced artificial egg counting time, and standardized artificial egg counts with more consistent and accurate readings. The current pilot study highlights the potential for future development and integration of the Stool Stomper device into the Kato–Katz technique to improve community-based STH treatment.
- 10 April 2025
- Published by SPIE-Intl Soc Optical Eng
- Vol. 13412, 20
Ultrasound and photoacoustic immunoimaging of nanoengineered T cells to guide and enhance cancer therapies (Conference Presentation)
Adoptive cell therapy (ACT) continues to fail at treating a majority of cancers. Advanced immunoimaging tools are needed to guide and enhance cellular immunotherapies to achieve greater treatment success. We developed a combined ultrasound (US) and photoacoustic (PA) imaging approach to: 1) improve T cell delivery to the primary tumor via magnetic guidance; 2) enable real-time, longitudinal monitoring of cell accumulation; and 3) assess response to therapy. Our approach leverages nanotechnology and cell surface engineering to safely tag the T cells, generate PA contrast for imaging post-transfer, and enable magnetic delivery. In vivo US/PA imaging results detected NP-labeled T cell accumulation at the tumor, visualized changes in tumor volume, and conveyed accompanying changes in blood biomarkers. Different US/PA imaging trends were observed according to a positive or negative anti-tumor response. Results demonstrate the potential of the approach and motivate further development of advanced, theranostic immunoimaging platforms.
- 10 April 2025
- Published by SPIE-Intl Soc Optical Eng
- Vol. 13412, 20
Ultrasound and photoacoustic immunoimaging of nanoengineered T cells to guide and enhance cancer therapies (Conference Presentation)
Adoptive cell therapy (ACT) continues to fail at treating a majority of cancers. Advanced immunoimaging tools are needed to guide and enhance cellular immunotherapies to achieve greater treatment success. We developed a combined ultrasound (US) and photoacoustic (PA) imaging approach to: 1) improve T cell delivery to the primary tumor via magnetic guidance; 2) enable real-time, longitudinal monitoring of cell accumulation; and 3) assess response to therapy. Our approach leverages nanotechnology and cell surface engineering to safely tag the T cells, generate PA contrast for imaging post-transfer, and enable magnetic delivery. In vivo US/PA imaging results detected NP-labeled T cell accumulation at the tumor, visualized changes in tumor volume, and conveyed accompanying changes in blood biomarkers. Different US/PA imaging trends were observed according to a positive or negative anti-tumor response. Results demonstrate the potential of the approach and motivate further development of advanced, theranostic immunoimaging platforms.
- Top Cited PapersOpen Access
- 5 February 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (6) , 6079-6094
In Vivo Ultrasound and Photoacoustic Imaging of Nanoparticle-Engineered T Cells and Post-Treatment Assessment to Guide Adoptive Cell Immunotherapy
Despite great promise, adoptive cell therapy (ACT) continues to fail at treating a majority of cancers, especially solid tumors. To inform development and expedite the translation of more potent cellular immunotherapies, advanced immunoimaging tools are needed to better understand the in vivo requirements for generating a robust immune response. Even methods to evaluate the delivery, location, and status of transferred T cells at the tumor target are lacking. Therefore, a real-time, safe, noninvasive, longitudinal imaging method is critically needed to 1) monitor adoptive T cell location and status and 2) assess treatment progression and response through imaging biomarkers. Here, we developed a combined ultrasound (US) and photoacoustic (PA) imaging approach to enable T cell tracking following adoptive transfer for cancer immunotherapy. Our approach leverages highly photostable gold nanorods and cell surface engineering to tag the T cells without impacting effector functions, as well as generate PA contrast for imaging post-transfer. Our in vivo US/PA imaging approach detected nanoparticle-labeled T cell accumulation at the tumor, visualized changes in tumor volume, and conveyed accompanying changes in blood biomarkers. US/PA data also showed different trends according to a positive or negative antitumor response to T cell therapy over 7 days. Results highlight the potential of the approach and motivate future development to expand the platform for advanced, theranostic immunoimaging.
- 5 February 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (6) , 6079-6094
Top Cited PapersOpen AccessIn Vivo Ultrasound and Photoacoustic Imaging of Nanoparticle-Engineered T Cells and Post-Treatment Assessment to Guide Adoptive Cell Immunotherapy
Despite great promise, adoptive cell therapy (ACT) continues to fail at treating a majority of cancers, especially solid tumors. To inform development and expedite the translation of more potent cellular immunotherapies, advanced immunoimaging tools are needed to better understand the in vivo requirements for generating a robust immune response. Even methods to evaluate the delivery, location, and status of transferred T cells at the tumor target are lacking. Therefore, a real-time, safe, noninvasive, longitudinal imaging method is critically needed to 1) monitor adoptive T cell location and status and 2) assess treatment progression and response through imaging biomarkers. Here, we developed a combined ultrasound (US) and photoacoustic (PA) imaging approach to enable T cell tracking following adoptive transfer for cancer immunotherapy. Our approach leverages highly photostable gold nanorods and cell surface engineering to tag the T cells without impacting effector functions, as well as generate PA contrast for imaging post-transfer. Our in vivo US/PA imaging approach detected nanoparticle-labeled T cell accumulation at the tumor, visualized changes in tumor volume, and conveyed accompanying changes in blood biomarkers. US/PA data also showed different trends according to a positive or negative antitumor response to T cell therapy over 7 days. Results highlight the potential of the approach and motivate future development to expand the platform for advanced, theranostic immunoimaging.
- Open Access
- 1 January 2022
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (4) , 1783-1799
Magnetic particles in motion: magneto-motive imaging and sensing
Superparamagnetic nanoparticles have become an important tool in biomedicine. Their biocompatibility, controllable small size, and magnetic properties allow manipulation with an external magnetic field for a variety of diagnostic and therapeutic applications. Recently, the magnetically-induced motion of superparamagnetic nanoparticles has been investigated as a new source of imaging contrast. In magneto-motive imaging, an external, time-varying magnetic field is applied to move a magnetically labeled subject, such as labeled cells or tissue. Several major imaging modalities such as ultrasound, photoacoustic imaging, optical coherence tomography, and laser speckle tracking can utilize magneto-motive contrast to monitor biological events at smaller scales with enhanced contrast and sensitivity. In this review article, an overview of magneto-motive imaging techniques is presented, including synthesis of superparamagnetic nanoparticles, fundamental principles of magneto-motive force and its utility to excite labeled tissue within a viscoelastic medium, current capabilities of magneto-motive imaging modalities, and a discussion of the challenges and future outlook in the magneto-motive imaging domain.
- 1 January 2022
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (4) , 1783-1799
Open AccessMagnetic particles in motion: magneto-motive imaging and sensing
Superparamagnetic nanoparticles have become an important tool in biomedicine. Their biocompatibility, controllable small size, and magnetic properties allow manipulation with an external magnetic field for a variety of diagnostic and therapeutic applications. Recently, the magnetically-induced motion of superparamagnetic nanoparticles has been investigated as a new source of imaging contrast. In magneto-motive imaging, an external, time-varying magnetic field is applied to move a magnetically labeled subject, such as labeled cells or tissue. Several major imaging modalities such as ultrasound, photoacoustic imaging, optical coherence tomography, and laser speckle tracking can utilize magneto-motive contrast to monitor biological events at smaller scales with enhanced contrast and sensitivity. In this review article, an overview of magneto-motive imaging techniques is presented, including synthesis of superparamagnetic nanoparticles, fundamental principles of magneto-motive force and its utility to excite labeled tissue within a viscoelastic medium, current capabilities of magneto-motive imaging modalities, and a discussion of the challenges and future outlook in the magneto-motive imaging domain.
- 26 September 2020
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 46 (12) , 3468-3474
A Trimodal Ultrasound, Photoacoustic and Magnetic Resonance Imaging Approach for Longitudinal Post-operative Monitoring of Stem Cells in the Spinal Cord
- 26 September 2020
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 46 (12) , 3468-3474
A Trimodal Ultrasound, Photoacoustic and Magnetic Resonance Imaging Approach for Longitudinal Post-operative Monitoring of Stem Cells in the Spinal Cord